Hematogenous and lymphatic tumor cell dissemination may be detected in patients diagnosed with ductal carcinoma in situ of the breast
✍ Scribed by Malgorzata Banys; Ines Gruber; Natalia Krawczyk; Sven Becker; Ralph Kurth; Diethelm Wallwiener; Jolanta Jakubowska; Jürgen Hoffmann; Ralf Rothmund; Annette Staebler; Tanja Fehm
- Publisher
- Springer US
- Year
- 2011
- Tongue
- English
- Weight
- 394 KB
- Volume
- 131
- Category
- Article
- ISSN
- 0167-6806
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Detection of disseminated tumor cells (DTCs) in bone marrow is an independent prognostic factor in primary breast cancer. Here, we conducted a proof‐of‐principle study to evaluate whether this tumor cell spread occurs already in patients with ductal carcinoma in situ (DCIS). After preop
## Abstract ## BACKGROUND The presence of isolated tumor cells (ITC) in the bone marrow at the time of primary diagnosis indicates an increased risk for subsequent development of distant metastases in various solid tumors. This study evaluates the prevalence and prognostic significance of ITC in p
## Abstract Despite an extensive surgical approach only 50% of the patients with medullary thyroid carcinoma (MTC) are biochemically cured. The failure to cure a larger number of patients is a result of the early dissemination of MTC. The present study evaluates two RT‐PCR based assays for the dete